Clinical efficacy and IgE levels of ebastine joint Compound Glycyrrhizin on acute and chronic urti-caria patients
- VernacularTitle:依巴斯汀联合复方甘草酸苷治疗急慢性荨麻疹的临床观察
- Author:
Guixiang CHANG
;
Liqing XING
;
Shuqiu ZHANG
- Publication Type:Journal Article
- Keywords:
Hives;
Ebastine;
Compound Glycyrrhizin on;
IgE
- From:
Journal of Chinese Physician
2015;(z1):1-3
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical efficacy of Ebastine joint Compound Glycyrrhizin in treatment of acute and chronic urticarial, and its effect on serum IgE levels.Methods Eighty cases of a-cute and chronic urticaria patients were collected from January 2010 to June 2014 in our hospital for treat-ment.They were randomly divided into control group and observation group, 40 cases in each group, the patients in the control group oral ebastine 10mg 1 times /day, patients in the observation group were given Compound Glycyrrhizin on 75mg and oral ebastine 10mg, 1 times /d, acute urticaria patients were treated for one week of continuous treatment, patients with chronic urticaria were treated for 4 weeks in a row;IgE level was measured by ELISA.Results After treatment, effective rate of patients with acute urticaria was 94.44%in the observation group, the control group was 68.42%; patients with chronic urticaria observa-tion group was 95.45%, the control group was 71.43%, a significant difference ( P <0.05 ) between the observation group and control group.IgE levels in both groups after treatment were reduced compared with before treatment ( P <0.01), after treatment IgE levels of patients had higher degree of improvement in the observation group, differences were statistically significant ( P <0.05).Conclusions The clinical effica-cy of ebastine joint Compound Glycyrrhizin on treatment of acute and chronic urticaria are better than single ebastine, two drugs used in conjunction with synergistic effect by regulating the body's immune function, re-duce allergy strength, improve efficacy.
